Collegium Pharmaceutical (COLL) Short-term Investments (2014 - 2026)

Collegium Pharmaceutical's Short-term Investments history runs 5 years deep, the most recent figure standing at $19.8 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 80.46% year-over-year to $19.8 million; the TTM figure through Mar 2026 stood at $19.8 million (down 80.46% YoY), while the FY2025 annual figure was $19.8 million, down 20.6% from the prior year.
• Short-term Investments was $19.8 million for Q1 2026 at Collegium Pharmaceutical, roughly flat from $19.8 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $135.8 million in Q3 2025 to a low of $19.8 million in Q4 2025.
• Historically, Short-term Investments has averaged $69.6 million across 4 years, with a median of $76.3 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Short-term Investments jumped 136.66% in 2024, then tumbled 80.46% in 2026.
• A 4-year view of Short-term Investments shows it stood at $71.6 million in 2023, then slumped by 65.08% to $25.0 million in 2024, then slipped by 20.6% to $19.8 million in 2025, then changed by 0.0% to $19.8 million in 2026.
• The last three Short-term Investments figures came in at $19.8 million (Q1 2026), $19.8 million (Q4 2025), and $135.8 million (Q3 2025), per Business Quant data.